PHVS
Pharvaris N.V.Company with tickers: PHVS
CIK
1830487
CUSIP
N69605108
Shares Outstanding
69,879,726
13F Activity (30d)
91 filings
90 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-04 | Nijdam Anna |
Principal Accounting Officer | Sell | 2,670 |
| 2026-05-22 | Nijdam Anna |
Principal Accounting Officer | Convert | 5,501 |
| 2026-05-22 | Nijdam Anna |
Principal Accounting Officer | Convert | 5,501 |
| 2026-05-22 | Nijdam Anna |
Principal Accounting Officer | Sell | 5,501 |
| 2026-05-21 | Nijdam Anna |
Principal Accounting Officer | Convert | 1,829 |
| 2026-05-21 | Nassif David W. |
CFO / CLO | Sell | 10,000 |
| 2026-05-21 | Monges Viviane |
Director | Sell | 9,667 |
| 2026-05-21 | Nijdam Anna |
Principal Accounting Officer | Sell | 1,829 |
| 2026-05-21 | Nijdam Anna |
Principal Accounting Officer | Convert | 1,829 |
| 2026-05-20 | Bjork Elisabeth |
Director | Convert | 10,000 |
| 2026-05-20 | Bjork Elisabeth |
Director | Sell | 10,000 |
| 2026-05-20 | Bjork Elisabeth |
Director | Convert | 10,000 |
| 2026-05-18 | Modig Berndt |
Director, Chief Executive Officer | Sell | 2,292 |
| 2026-05-15 | Souverijns Wim |
Chief Commercial Officer | Sell | 10,000 |
| 2026-05-15 | Glassman Robert |
Director | Convert | 5,333 |
| 2026-05-15 | Glassman Robert |
Director | Sell | 4,667 |
| 2026-05-15 | Abele Stefan Andreas |
Chief Technical Ops Officer | Sell | 8,748 |
| 2026-05-15 | Glassman Robert |
Director | Sell | 5,333 |
| 2026-05-15 | Glassman Robert |
Director | Convert | 5,333 |
| 2026-05-12 | Lu Peng |
Chief Medical Officer | Tax | 117 |
| 2026-05-11 | Lu Peng |
Chief Medical Officer | Tax | 109 |
| 2026-05-01 | Lu Peng |
Chief Medical Officer | Sell | 14,023 |
| 2026-05-01 | Lu Peng |
Chief Medical Officer | Sell | 143 |
| 2026-05-01 | Lu Peng |
Chief Medical Officer | Convert | 14,166 |
| 2026-05-01 | Lu Peng |
Chief Medical Officer | Convert | 14,023 |
| 2026-05-01 | Lu Peng |
Chief Medical Officer | Convert | 143 |
| 2026-04-30 | Lesage Anne |
Chief Early Development | Convert | 3,700 |
| 2026-04-30 | Lesage Anne |
Chief Early Development | Convert | 3,700 |
| 2026-04-30 | Lesage Anne |
Chief Early Development | Sell | 19,200 |
| 2026-04-30 | Schikan Johannes Gerardus Christiaan Petrus |
Director | Sell | 670 |
| 2026-04-30 | Lesage Anne |
Chief Early Development | Convert | 18,000 |
| 2026-04-30 | Lesage Anne |
Chief Early Development | Convert | 18,000 |
| 2026-04-30 | Schikan Johannes Gerardus Christiaan Petrus |
Director | Sell | 28,400 |
| 2026-04-30 | Lu Peng |
Chief Medical Officer | Convert | 15,000 |
| 2026-04-30 | Lu Peng |
Chief Medical Officer | Sell | 15,000 |
| 2026-04-30 | Lesage Anne |
Chief Early Development | Sell | 18,000 |
| 2026-04-30 | Lu Peng |
Chief Medical Officer | Convert | 15,000 |
| 2026-04-30 | Lesage Anne |
Chief Early Development | Sell | 3,700 |
| 2026-04-29 | Lesage Anne |
Chief Early Development | Sell | 3,700 |
| 2026-04-29 | Lesage Anne |
Chief Early Development | Convert | 3,700 |
| 2026-04-29 | Lu Peng |
Chief Medical Officer | Convert | 3,733 |
| 2026-04-29 | Lu Peng |
Chief Medical Officer | Convert | 3,733 |
| 2026-04-29 | Schikan Johannes Gerardus Christiaan Petrus |
Director | Sell | 3,830 |
| 2026-04-29 | Lu Peng |
Chief Medical Officer | Sell | 3,733 |
| 2026-04-29 | Lesage Anne |
Chief Early Development | Convert | 3,700 |
| 2026-04-29 | Lesage Anne |
Chief Early Development | Sell | 3,700 |
| 2026-04-23 | Schikan Johannes Gerardus Christiaan Petrus |
Director | Sell | 100 |
| 2026-04-23 | Lu Peng |
Chief Medical Officer | Sell | 100 |
| 2026-04-23 | Lesage Anne |
Chief Early Development | Sell | 100 |
| 2026-04-23 | Lesage Anne |
Chief Early Development | Sell | 100 |
Showing 1–50 of 162 transactions